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ABSTRACT

INTRODUCTION: Immunization is an intervention proven to reduce morbidity and
mortality for several infectious diseases, yet coverage remains less than optimal,
especially among minorities and the poor. Challenges to adequate coverage are
associated with access and consolidated immunization documentation to support clinical
immunization decision making. Efforts to improve access and service delivery include
Community Guide recommended interventions, the Vaccines for Children (VFC)
Program, and electronic data exchange between provider electronic health records (EHR)
and state and city immunization information systems (IIS).
AIM: The purpose of this study is to 1) determine if EHR-IIS interoperability improves
immunization outcomes and 2) identify how EHR-IIS interoperability may improve the
capacity to support activities to increase appropriate immunization.
METHODS: Data reported by state IIS for immunization provider sites both prior to and
after the establishment of or the improvement of an existing EHR-IIS interface were
analyzed to examine changes in 1) the mean difference in the proportion of 19 to 35
month old children at these sites who were up-to-date for age-appropriate immunizations,
and 2) the mean difference in completion of key demographic and vaccine-related fields
for 4m to 6 year-old children associated with enhanced sites in the IIS.
RESULTS: Statistical analysis yielded evidence of a positive change in the mean
difference in the proportion of children aged 4m to 6 years with key demographic and
vaccine data in IIS. A statistically significant change in the mean difference of up-to-date
status in 19 to 35 month olds was not detected.
DISCUSSION: Evidence suggests that EHR-IIS interoperability can improve the
capacity of IIS in targeting of immunization services to underserved populations and
support accountability for the VFC program. Implementation of EHR-IIS interfaces must
be performed thoughtfully and with an understanding of the impact of the interface on IIS
data used to support immunization program activities. Immunization outcomes for
children at provider sites engaging in electronic data exchange with IIS should continue
to be monitored. Additional analysis must be done to identify the interoperability factors
that are positively and negatively associated with improved immunization outcomes.
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Chapter I
INTRODUCTION
1.1 Background
1.1.1

Immunization in the United States
Considered one of the ten great public heath achievements of the 20th century in the

United States, immunizations are credited with the substantial reduction in mortality for several
infectious diseases (“Achievements in public health,” 1999). Although current vaccination
coverage rates indicate the overall success of the United States’ immunization program, coverage
remains inadequate in certain segments of the U.S. population, particularly among those in racial
and ethnic minorities and those living in poverty (“National,” 2015).
Prior to the development of vaccines, infectious diseases were highly prevalent in the
U.S. and caused illness and death in thousands of individuals (“Achievements in public health,”
1999). Since 1900, effective vaccinations against several diseases, including smallpox,
diphtheria, pertussis, tetanus, poliomyelitis, measles, mumps, rubella, and Haemophilus
influenzae type b (Hib) have been developed and systematically implemented by state
immunization programs across the country. Vaccines have proven to be an overwhelmingly
successful intervention, decreasing deaths caused by these diseases by at least 95%, and in the
case of smallpox, by 100% (Orenstein, Rodewald & Hinman, 2004). Failure to sustain adequate
vaccination levels, however, can leave the population vulnerable to disease, particularly due to
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importation from other countries. This threat manifested when a measles outbreak occurred from
1989 to 1991 (Hinman, Orenstein & Papania, 2004), and most notably again in 2014 and 2015
associated with Disney theme parks in California (“Measles Outbreak,” 2015).
Incidence of vaccine-preventable diseases (VPDs) imposes not only direct health care
costs such as those from medical care and hospitalization, but also indirect societal costs such as
those stemming from missed work, permanent disability, and premature mortality (Whitney,
Zhou, Singleton & Schuchat, 2014). Racial and ethnic minorities and those living in poverty
have long experienced lower immunization coverage (“Vaccination coverage,” 1997; “National,”
2015), and the risk of disease and death has therefore been and continues to be disproportionately
borne by these populations.
1.1.2. Challenges in Immunization
Although vaccinations are clearly an effective intervention to preventing morbidity and
mortality associated with several infectious diseases, challenges remain in the successful delivery
of this essential service, such as the increasing complexity of the recommended vaccine
schedule. The 2015 Advisory Committee on Immunization Practices (ACIP) recommended
vaccination schedule includes 23 to 25 routine vaccinations for all children (“Recommended”,
2015) by 18 months of age, which is an increase from the 15 to 19 vaccinations recommended
circa 2000, and the 8 vaccinations recommended roughly 20 years prior to that (Stokley,
Rodewald & Maes, 2001). These clinical guidelines are also accompanied by complex
specifications for minimum ages and intervals between doses as well as contraindications and
precautions (Centers for Disease Control and Prevention [CDC], “IIS - Clinical Decision
Support,” 2015). In addition, the increasing use of combination vaccines that contain antigens
targeting more than one VPD also requires providers to be aware of which combination vaccine
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was administered as well as its individual components (Abramson, Kaushal & Vest, 2014).
Making appropriate clinical immunization decisions in the face of evolving and complicated
vaccine products and recommendations is not only difficult, but also prone to inconsistency
(CDC, “IIS - Clinical Decision Support,” 2015).
Another challenge to reaching and sustaining sufficient coverage against VPDs is
incomplete documentation of immunizations. Clinical immunization decision-making is
performed by reviewing a child’s immunization history and determining immunizations needed
by consulting the recommendations in the ACIP schedule. Lack of a comprehensive record of
prior immunizations can therefore contribute to inaccurate immunization recommendations, and
in fact has been shown to significantly compromise a provider’s ability to accurately assess
immunization status and consequently determine what immunizations are needed when a child
presents for care (Stokley et al., 2001). Healthcare providers are required by the National
Childhood Vaccine Injury Act of 1986 to document immunization information in their patients’
medical chart such as vaccine administration date, vaccine manufacturer and lot number, and
vaccine provider name and address (National Vaccine Injury Compensation Program [NVICP],
2015), and are generally considered the most reliable source of immunization information.
However, children can receive immunizations at locations other than their current medical home
such as at the health department or their previous primary care provider. In addition, parents
often fail to bring documentation of prior immunization to their child’s initial visit to a new
provider office. Immunization records are consequently often scattered across multiple locations,
thus putting the provider at risk of making immunization decisions based on incomplete
information (Stokley et al., 2001). Such circumstances can also result in the administration of
unneeded doses and wasting of valuable resources (Feikema, Klevens, Washington & Barker,
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2000). In 2000 Feikema et al. found that an estimated 21.1% of children received at least one
extra dose of vaccine, totaling 1.8 million doses and representing $26.5 million in costs
associated with vaccine, administration, and clinic visits. In the aftermath of Hurricane Katrina,
record lookup enabled by electronic Health Level 7 (HL7) interfaces saved $1.6m in vaccine and
$3.04m in vaccine and administration fees for individuals who relocated to other states. (Boom,
Dragsbaek & Nelson, 2007) Elementary schools, because they require vaccination records for
children prior to enrollment, may have more complete information than a single provider,
however, according to federal Family Educational Rights and Privacy Act (FERPA) regulations,
immunization records are considered part of the academic record and as such cannot be redisclosed by schools without parental consent. This regulation thus imposes an additional
administrative burden and creates a barrier to sharing of immunization information and the
collation of a complete immunization record. (Bobo, Etkind, Martin, Chi, & Coyle, 2013).
1.1.3. Initiatives to Improve Immunization Coverage
1.1.3.1 Vaccines for Children Program
Research on the aforementioned measles outbreak in the late 1980s and early 1990s
revealed that a disproportionate number of cases were among poorer, inner-city pre-school aged
children of black, Hispanic, or American Indian heritage. These findings led to the inception of
the Childhood Immunization Initiative 1993, which sought to reduce disparities in immunization
coverage among U.S. children. Part of this initiative was the establishment of the Vaccines for
Children (VFC) program in 1994. This program, administered by the CDC, purchases vaccines
and distributes them to participating providers at no cost for administration to children under 18
years of age who meet specified eligibility criteria. Children are eligible to receive VFC vaccine
if they are uninsured, underinsured, Medicaid-eligible, or of American Indian/Alaska Native
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race/ethnicity (Smith, Lindley & Rodewald, 2011). The program is the largest administered by
the CDC with almost $1billion spent in fiscal year 2004 alone (Ching, 2007) and, due to the
growing number of recommended immunizations and increasing costs, to nearly $3billion in
2007 (Metroka, Hansen, Papadouka & Zucker, 2009), with the majority of the VFC budget,
approximately 90%, used to purchase vaccine (Ching, 2007). Although vaccine is provided at no
cost to participating providers through this program, there are a number of administrative tasks
associated with its implementation in provider offices (Bartlett, Washington, Bryant, Thurston &
Perfili, 2007). Data required by VFC state policies for accountability include the vaccine
recipient’s race and ethnicity in order to assure they meet the eligibility requirements of the
program, as well as data related to the vaccine itself in order to support vaccine ordering and
inventory management (Office of the Inspector General, 2012), such as vaccine manufacturer
and lot number of the dose administered, and to document that VFC vaccine was administered
only to VFC-eligible children (Office of the Inspector General, 2012). Although necessary for
accountability purposes, these administrative and reporting requirements were, according to a
1999 provider satisfaction survey, the least popular aspect of an otherwise well-received program
(Zimmerman et al., 2001). A recent economic evaluation of this program found that an
estimated $402 billion in direct and $1.5 trillion in societal costs have been saved by vaccination
since the inception of this program (Whitney, Zhou, Singleton & Schuchat, 2014).
1.1.3.2 The Guide to Community Preventive Services’ Recommended Interventions to
Increase Appropriate Immunization
The Guide to Community Preventive Services (“the Community Guide”) researches
interventions for improving health and preventing disease to identify those that, on the basis of
systematic review of the scientific literature, have been proven effective. The Community Guide
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therefore serves as a resource for public health programs, including immunization, by providing
information about interventions proven to be effective. The Community Guide has researched
several vaccination interventions and since 2008 has identified thirteen different effective
interventions for improving immunization coverage. These interventions are grouped within
three categories: those that improve access to vaccination, those that increase community
demand for vaccinations, and those that are provider- or system-based. The interventions proven
to improve access are home visits, reducing out-of-pocket costs, school- or child care centerbased programs, and programs conducted in Special Supplemental Nutrition Program for
Women, Infants, and Children (WIC) clinics. Interventions recommended that increase
community demand for vaccination are: monetary incentives, reminder/recall, community-wide
interventions used in combination, and vaccination requirements for day care, school or college.
Provider- or systems-based interventions recommended by the Community Guide are: health
care system-based interventions implemented in combination, provider assessment and feedback,
provider reminders, and standing orders. In 2010, on the basis of their ability to support both
public health and private provider immunization activities, the Community Guide added
immunization information systems to their list of recommended provider- or systems-based
interventions (The Community Guide, 2010).
1.1.3.3.

Immunization Information Systems

As defined by the Community Guide, immunization information systems (IIS) are
“confidential, population-based, computerized databases that record all immunization doses
administered by participating providers to persons residing within a given geopolitical area”
(Groom et al, 2014, p.2).
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With high levels of participation by providers within its jurisdiction:
“At the point of clinical care, an IIS can provide consolidated immunization histories for
use by a vaccination provider in determining appropriate client vaccinations.
At the population level, an IIS provides aggregate data on vaccinations for use in
surveillance and program operations, and in guiding public health action with the goals of
improving vaccination rates and reducing vaccine-preventable disease.” (Groom et al,
2014, p.2).
IIS facilitate the delivery of immunizations by performing several functions that support
evaluation of immunization status on both an aggregate and individual basis. Public health
officials and state and city immunization programs can use IIS data to evaluate immunization
coverage at mulitple levels such as county, zip code, vaccine type, or even by individual provider
or provider organization. With such information, programs can identify pockets of need in their
communities or identify provider education needs should it appear that a provider’s coverage rate
for a specific antigen is inconsistent with other vaccines. Public health can also use IIS data to
support outbreak response, vaccine recalls, evaluate trends in immunization coverage, and
partner with other stakeholders to perform other immunization–related research (Groom et al,
2014).
In the clinical setting, participating providers can access the immunization record at the
time of service for a child in their state or local IIS who presents for care. If the provider has not
treated that child previously, the provider or his staff may access their record in the IIS if the
child’s previous provider reported the immunizations they administered to the IIS. After
enrollment in an IIS, the system will, based on computerized algorithms, recommend
vaccinations due based on the ACIP recommended schedule and the child’s previous
immunization history. Any contraindications to vaccination can be recorded, or, should any exist
during the encounter, the provider may document them. When immuizations are administered,
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the provider can document information related to VFC eligibility status, such as the child’s race
and ethnicity, as well as record information such as manufacturer, lot number, dosage, and
administration site for the vaccines given. If a provider uses the IIS’s vaccine inventory
management system, doses will be decremented from their inventory, streamlining the ordering
and replishment process. If a parent requests a copy of their child’s record, one can be printed
directly from the IIS and given to the parent. A provider may also query the IIS for their
practice’s immunization coverage rate, and even produce a list of patients that are due or overdue
for vaccination to perform reminder/recall. If a provider uses an Electronic Health Record
(EHR), then depending on the functinality of the EHR and its capacity to support Health Level 7
(HL7), the established data exchange format for immunizations, these data can be entered into
the EHR instead of into the IIS and then extracted and reported to the IIS, eliminating any
duplicate data entry (Linkins & Feikema,1998).
1.1.3.4

National Health Information Technology Policies
Recently enacted national policies aiming to improve health care quality in the U.S. have

resulted in the creation of programs that impact IIS and have provided large amounts of funding
to implement them. The American Recovery and Reinvestment (ARRA) and the Health
Information Technology for Economic and Clinical Health (HITECH) Acts of 2009
(Blumenthal, 2009), the Patient Protection and Affordable Care Act (ACA) (Office of the
Legislative Counsel, 2010) and the Prevention and Public Health Fund (PPHF) (Department of
Health and Human Services [DHHS], 2015), and the Centers for Medicare and Medicaid
Services (CMS) Meaningful Use Program enacted in 2010 (CDC, “IIS – Meaningful Use,” 2012)
all promote the use of health information technology as a means to improve the quality of health
services. The overarching vision of these initiatives is to bridge the gap between the private and
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public sectors to contribute to the creation of a unified health information network. The
Meaningful Use initiative in particular seeks to drive the adoption of Electronic Health Record
Systems (EHR) by private providers and promote the exchange of data between these systems
and public health (CDC, “IIS – Meaningful Use,” 2012). In addition, ARRA and ACA-PPHF
funding has been provided to develop and implement programs to support the creation of
interfaces between EHR and IIS (Blumenthal, 2009; DHHS, 2015). The interfacing of EHR to
IIS, or EHR-IIS interoperability through these funding opportunities, will increase the quantity of
immunization data in IIS, and, it is believed, improve immunization outcomes and the capacity
of IIS to improve population health (American Recovery and Reinvestment Act [ARRA], 2015;
DHHS, 2015).
Funding for EHR-IIS Interoperability was made available to immunization programs
through competitive funding process with ARRA funds in 2010, again with ACA-PPHF funds in
2012, and still continue. The purpose of these programs was to provide support for vaccination
data exchange between provider site EHRs and their state or local IIS with a specific focus of
reducing the duplicate data entry burden on providers. The program rationale was that by
supplanting other less rigorous IIS reporting methods, the implementation of standardized
electronic data exchange using the HL7 standard between EHR and IIS would yield the
following benefits: improved completeness of client demographic information and
immunization histories available to clinicians and public health, improved timeliness of
immunization data submission to an IIS, improved quality of IIS coverage assessments, and an
increase in the data available to other public health systems (e.g. vaccine preventable disease
surveillance units). In addition, it was reasoned that improved interoperability would also reduce
extra immunization, thereby saving time and resources (ARRA, 2015; DHHS, 2015).
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Required activities under these programs included the identification of large, highvolume provider practice sites that immunize children less than six years of age that use EHR
products and collaborate with them to implement interoperable interfaces between their EHR
products and their IIS. Collaborative activities consisted of upgrading their IIS to support HL7
data exchange, supporting the upgrade of provider site EHRs to support HL7, HL7 message
formatting and testing, data quality evaluation and the implementation and ongoing monitoring
of HL7 electronic data submission to IIS (ARRA, 2015; DHHS, 2015). Figure 1 presents a logic
model of the interoperability of EHR with IIS in terms of Inputs, Outputs, and expected Short-,
Intermediate- and Long-Term Outcomes.
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Figure 1: Logic Model for ARRA and ACA-PPHF Electronic Health Record and Immunization Information Systems Interoperability
Cooperative Agreements
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1.2 Purpose of Study
The purpose of this study is to examine the impact of EHR-IIS interoperability on
immunization outcomes and on the completeness of data in IIS, as measured by up-to-date status
of 19 to 35 month old children at provider sites reporting immunization data to IIS from their
EHR, and by the population of key data fields in IIS for children less than six years of age,
respectively. This study will also examine the potential for EHR-IIS interoperability to impact the
capacity of IIS to support activities to increase appropriate immunization.
1.3 Research Questions
This study set out to examine these issues by asking the following two research questions:
1) Does interoperability between EHR and IIS improve immunization outcomes?
2) How can EHR-IIS Interoperability improve the capacity of IIS to support activities
to increase appropriate immunization?
These questions will be answered by analyzing data on immunization and demographic
information reported to IIS by providers to selected state and city immunization program
recipients of ARRA and ACA-PPHF funds for EHR-IIS interoperability programs. These data
include multiple metrics at the provider site level collected both prior to and after the
implementation of electronic immunization reporting from their EHR to their statewide IIS. The
metrics used for this study are the up-to-date status for children aged 19 to 35 months, and
completeness of the following immunization and demographic data fields: vaccine manufacturer,
vaccine lot number, mother’s first name, mother’s last name, child race, and child ethnicity.
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Chapter II
REVIEW OF THE LITERATURE
A literature search was conducted to catalogue evidence for IIS support of Community
Guide-recommended immunization promotion activities for U.S. children less than six years of
age and the use of population-based IIS to support and evaluate aspects of immunization delivery.
Supplemental searches were also conducted to characterize the functional capacity of IIS across
the nation, the level of adoption of EHR in the United States, and to identify other studies that
have been conducted to evaluate the impact of EHR and also of EHR-IIS interoperability.
2.1 Use of Population-Based IIS for Immunization Promotion Activities for U.S. Children
Less than Six Years of Age and for Evaluating Immunization Delivery – Method
First, the Community Guide’s findings from their systematic review of the literature on IIS in
2014 (Groom et al., 2014) were consulted. Their review included literature on IIS published from
1994 through 2011 as well as study findings presented at conferences. It included IIS studies in
non-U.S. countries involving populations of all ages, and also on non-population-based IIS (e.g.,
IIS not populated using birth records). Studies that were included as evidence in the review were
retrieved, and because this current study is concerned with only the IIS and population impacted
by ARRA and ACA-PPHF EHR-IIS interoperability IIS in the United States, additional inclusion
criteria were applied.
Of the 246 Community Guide studies, only studies were included that:
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were published in a peer-reviewed journal,
were conducted in the United States,
used data from a population-based IIS, or merged data with that from a populationbased IIS;
were done on study populations of children under 6 years of age, and
reported one or more quantitative outcomes.

Second, in addition to those studies from in the Community Guide review, a subsequent
search was conducted to identify relevant studies published after 2011. Using the same search
criteria within the same library databases used for the Community Guide review, 248 studies were
identified. After application of the inclusion criteria and deduplication, a total of 30 journal
articles remained.
Data were abstracted from the studies to identify the following:




2.1.1

Evidence for IIS support of immunization promotion activities targeting children <6
How IIS supported Community Guide evidence-based recommended interventions
Use of IIS to evaluate immunization coverage for specific age groups
Use of IIS to research and evaluate immunization delivery

Evidence for IIS support of immunization promotion activities for children less than
6 years of age
Dombkowski, Harrington, Dong and Clark (2012) and Kempe et al. (2013) both

documented the use of a statewide IIS in guiding immunization outreach using reminder recall.
Dombkowski et al. assessed the feasibility of specialized use of the Michigan Care Improvement
Registry (MCIR), Michigan’s statewide IIS, for vaccine reminders for seasonal influenza, an
annual immunization promotion activity. They used MCIR to target reminder notices to high-risk
children aged 24 to 60 months, and found that receipt of a reminder was positively linked to flu
vaccination for the target population (2012). Kempe et al. also examined the use of an IIS for
immunization reminder recall activities, but compared the efficacy and cost-effectiveness of
population-based recall performed by public health to practice-based recall done by private
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providers in increasing immunization rates for preschool children (2013). They found that recall
notices sent to households from provider offices were more effective at raising immunization
rates yet were more costly, but that only 5% of practices in the intervention actually did so, citing
lack of time (2013). Both studies also cited a high rate of returned notices due incorrect addresses
and highlighted the importance of updated contact information in the IIS (Dombkowski et al.,
2012; Kempe et al., 2013).
Researchers in Kansas used the Kansas statewide IIS to evaluate a pilot test of a childhood
immunization intervention program, Text Reminders for Immunization Compliance in Kids
(TRICKs). They found that a higher proportion of children whose parents received text message
reminders had received their immunizations, and received them on time (Ahlers-Schmidt et al.,
2012). As with Dombkowski et al. and Kempe et al., this study experienced issues with contact
information, reporting that approximately 40% of the parents enrolled lost mobile phone service
seven months into the study and recommended that supplemental contact information should be
collected from parents upon enrollment. Post-intervention interviews with parents yielded
additional suggestions to send reminders to more than one number, and also to include specific
information about their child’s appointment in the message (2012).
Feemster, Spain, Everhart, Pati and Watson (2009) used data in the Philadelphia IIS to
identify the maternal and provider characteristics of children at risk for late initiation of
immunization. They found that younger maternal age, fewer prenatal care visits, increased
number of older siblings, and use public health clinic services were the predictors most strongly
associated with a child being a late starter. One outcome of this research is that this information
is being used by the Philadelphia Immunization Program to inform immunization promotion
activities, such as partnering with maternal and child health services and obstetricians. The

16

author also suggests introducing vaccine education prenatally (Feemster et al., 2009). In a
simpler study, Stille & Cristison-Lagay (2000) used the Connecticut statewide IIS to inform chart
reviews for inner-city infants, and found that up-to-date status for the study cohort increased by
5% after consulting CIRTS. The IIS data contributed to a more complete understanding of
immunization status, thereby reducing extraimmunization and allowing redirection of promotion
efforts to those children who were truly behind (Stille & Cristison-Lagay, 2000).
Similar to Feemster et al., Weston and Enger (2010) leveraged the MCIR system to
identify factors associated with the receipt of hepatitis A vaccine in Michigan one-year-olds, and
also assess overall hepatitis A coverage among this group. Authors cited using a number of
variables from the MCIR system: gender, race/ethnicity, mother’s age, provider type, Medicaid
and WIC status, and zip code. They found that 55.8% of their age group of interest received at
least one dose of hepatitis A vaccine by 24 months of age. They also found that black and
Hispanic children enrolled in WIC, Medicaid or both programs had higher odds of vaccine
receipt. Additional characteristics associated with vaccine receipt were residing in a non-rural
area and receiving care from a public provider. These findings prompted recommendations to
examine the nature of who and how this particular vaccine is promoted and if it was different than
promotion methods for other immunizations (2010).
Daskalaki, Spain, Long, and Watson (2008) also performed a study to examine aspects of
coverage with respect to one vaccination. Their study examined rotavirus vaccination and the
impact of the strict age limits for initiation for this vaccine series on coverage for other
vaccinations, and how many providers complied with the age recommendation and how many did
not. Using demographic and vaccination data from the Philadelphia IIS, the authors found that
children served by public health clinics initiated the DTaP vaccine series too late, leaving them at
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risk and vulnerable to VPDs. The authors emphasize that adherence to timeliness
recommendations has been observed to be increasingly important in protection against vaccinepreventable diseases. Consequently, the capacity to perform this type of study is valuable to
determine the prevalence of vaccine delay and identify ways to address this issue. On the basis of
their findings, the study authors recommend changing the age at which promotion initiatives are
triggered from ten months to three months, and also consider conducting these activities at the
birth hospital in order to facilitate identification of mothers with other risk factors that may put
their newborn at risk (2008).
Livingood and colleagues (2013) described the use of the Florida IIS to assist in the
evaluation of a quality improvement (QI) initiative to improve immunization rates for two yearolds conducted within the state’s immunization program. The statewide IIS, Florida SHOTS, was
used as the primary data source for measuring immunization rates during the project, which used
QI methods to improve implementation of evidence-based approaches for improving
immunization. Staff generated coverage reports for 19 to 35 month old children throughout the
project, and revealed consistent and steady improvement in coverage rates (Livingood et al.,
2013).
2.1.2

Use of IIS to Support Community Guide Recommended Interventions to Increase
Appropriate Immunization
Several studies from the literature review documented the use of Community Guide-

recommended evidence-based interventions. The studies performed by Dombkowski et al.,
Kempe et al., and Ahlers-Schmidt et al. described above, all used IIS to perform reminder/recall,
one of the Community Guide’s recommended interventions for increasing community demand for
immunization. Findley et al. also documents the use of reminder recall, but as one piece of a
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larger evaluation of a multi-component, coalition-led immunization intervention program, or as
the Community Guide would characterize the effort, a community-based intervention
implemented in combination, another of the Community Guide’s recommended activities for
increasing demand. Using the population-based New York Citywide Immunization Registry
(NYCIR) as their immunization data source, the Start Right coalition performed multiple
activities in this campaign to target the Latino, low-income community, which was understood to
have coverage lower than both city and national rates. These activities included the development
of promotional materials, training health educators, performing outreach, education, and parent
reminders (2012). As the sole source of immunization data used for the population, NYCIR
helped document and track immunization rates for the children targeted by the intervention, and
the program found that children receiving coalition services were 53% more likely to be up to
date than children in the control group (2012).
Kattan, Kudish, Cadwell, Soto and Hadler (2014) also describes the implementation of a
multi-pronged immunization intervention in Connecticut, where Immunization Action Plan (IAP)
coordinators to target immunization promotion activities for a provider- and systems-based
intervention in areas of low socioeconomic status (2014). These coordinators used CIRTS data to
identify the children within their assigned area who were behind schedule at seven months of age,
and then carried out a number of actions to get them caught up. Among those activities were
home visits, returning the child to care by assigning them to a medical home, supporting
implementation of reminder recall at the provider site, and performing evaluation and feedback to
the provider. Study authors emphasized that the implementation of coordinators in combination
with the information in the IIS was key to minimizing the disparities in immunization coverage
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within the population and helping them achieve full protection by twenty-four months of age
(2014).
2.1.3 Use of IIS to Evaluate Immunization Coverage for Specific Age Groups
As described above, IIS can be effectively used to isolate immunization status of different
segments of the population based upon health risk (Dombkowski et al., 2012) and even create risk
profiles for children based upon a number of characteristics (Feemster et al., 2009), such as
census tract (Kattan et al., 2014). IIS that are population-based and enroll children in their
systems using birth certificate data, due to having data on almost the entire child population their
jurisdiction, therefore have the potential to perform analysis on the entire IIS jurisdiction for any
number of age groups. This literature review alone identified studies examining twenty different
age groups. Four studies examined the six month to five year old population(CDC, 2006; CDC,
2007; CDC, 2008; Ma, 2006), three examined the 19 to 35 month-old population (Findley et al.,
2008; Kempe et al., 2013; Khare et al., 2013), and two studies examined the nine month
population and the 24 month-old population (Robison et al., 2012; White et al., 2011). All other
studies looked at unique groups, ranging from very young populations such as newborns less than
three days old (White, Anderson, Stanley & Ehresmann, 2009) to a one-year cohort for which
coverage was calculated at milestone ages (Robison, Kurosky, Young, Gallia & Arbor, 2010).
2.1.4 IIS Use of IIS to Research and Evaluate Immunization Delivery
In addition to the studies described above, other studies included in this literature
described a number of applications of IIS data for the research and evaluation of immunization
delivery. Two studies used IIS data to evaluate vaccine effectiveness or safety (Cortese et al.,
2011; Guh & Hadler, 2011) and two evaluated the impact of vaccine shortages on immunization
coverage levels (Allred et al., 2006; White, Pabst & Cullen, 2011). One described the use of a
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city-wide IIS in notifying providers of a vaccine recall (Papadouka, Metroka & Zucker, 2011),
and another described the use of the Delaware IIS to support public health response in a pertussis
outbreak in an Amish population (CDC, 2006). Other studies assessed provider compliance with
vaccine recommendations (Allred et al., 2006; Bronson-Lowe & Anderson, 2009); two
specifically examined the use of alternative vaccination schedules (Nadeau et al., 2015; Robison,
Groom & Young, 2012). One researcher evaluated the effect of media coverage on flu
vaccination in 2003 (Ma et al., 2006) and another the impact of the medical home on
immunization rates (Ortega, Stewart, Dowshen & Katz, 2000). IIS have also partnered with
Managed Care Organizations in conducting research as well, evidenced by Happe, Lunacsek,
Marshal, Lewis and Spencer in 2007, which examined the impact of the use of a combination
vaccine on timeliness of vaccination and coverage rates for their enrollees.
IIS, which operate at state and city levels, are also being increasingly examined for how
they may support national-level vaccination surveillance. Khare, Piccinino, Barker and Linkins in
2006 described the use of IIS as supplemental data sources for the National Immunization Survey,
which is a survey conducted annually by CDC to develop estimates of immunization coverage for
states and large metropolitan areas (CDC “National,” 2015).
One of the strengths of IIS for evaluating immunization coverage and delivery is their
capacity to use their data to perform geographical analysis, stratifying immunization coverage by
using certain variables with geographic data in the IIS and enabling the identification of
geographic pockets of need that have lower immunization rates and may need special attention.
Analysis of IIS data by address information, including street address, county, or zip code was
described in thirteen studies (Allred et al., 2006; Cortese et al., 2011; Daskalaki et al., 2008;
Dombkowski et al., 2012; Feemster et al., 2009; Guh & Hadler, 2011; Kattan et al., 2014; Kempe
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et al., 2013; Livingood, et al., 2013; Nadeau et al., 2015; Robison et al., 2010; Robison et al.,
2012; and Weston & Enger, 2010). Six of these studies recounted leveraging the data fields that
are of interest in this study. Two studies used vaccine manufacturer and four used race and
ethnicity in conjunction with their geographic data analysis. Robison et al. used vaccine
manufacturer in his analysis of a one-year cohort’s progress through early immunization
milestones (2010), and Cortese et al. (2011) used vaccine manufacturer and lot number in her
rotavirus vaccine effectiveness study. Race and ethnicity data were used in combination with
geographical analysis to evaluate the effect of late initiation of rotavirus vaccine (Daskalaki et al.,
2008), characterize geographic distribution and sociodemographic characteristics of children who
are “late starters” (Feemster et al., 2009), evaluate the effect of immunization coordinators on
socioeconomic disparities in immunization (Kattan et al., 2014), and identify the factors
associated with hepatitis A vaccination receipt in one-year-olds in the IIS jurisdiction (Weston &
Enger, 2010).
Similar to the Community Guide review, this review found few studies that addressed
provider consultation of the data in the IIS. As described above, Kempe et al. compared providerbased reminder recall with population-based recall done by public health (2013). Zeretke et al.
(2012) described a study that evaluated the effect of consulting an IIS for documentation of
immunization for children presenting with fever in the emergency room, found that consulting the
IIS for vaccine histories resulted in a 58% reduction in the ordering of blood work.
2.2 Functional Capacity of IIS in the United States
Since 1994, the Centers for Disease Control and Prevention (CDC) has allocated funds
annually to its immunization program awardees for the development and implementation of IIS
under Section 317(b) of the Public Health Service Act. Throughout this process, CDC has
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assisted in developing functional standards, setting performance goals and monitoring IIS
progress. As of the end of calendar year 2012, 86% of children less than six years of age had at
least two immunizations in an IIS (“Progress in Immunization Information Systems,” 2013).
Table 1 lists Functional Standards for IIS and the percentage that reported compliance with them
in the Calendar Year 2012 Immunization Information Systems Annual Report (IISAR). These
Functional Standards were developed with input from a variety of immunization program
managers and IIS developers across the U.S., endorsed by the National Vaccine Advisory
Committee (NVAC), and represent fundamental capabilities that IIS should posses in order to
fulfill their purpose of supporting immunization providers and public health programs in the
delivery of immunizations and assuring appropriate levels of population protection from vaccine
preventable diseases (CDC, “IIS – Functional Standards,” 2012).
As shown in Table 1, all IIS reported the capacity to enable access to a child’s
immunization history at the time of the clinical encounter and 96% reported the ability to forecast
Table 1: Percentage of IIS Meeting CDC Functional Standards, Immunization Information
Systems Annual Report, 2012 (Cardemil, Ng & Pabst, 2013).
IIS Functional Standard
% IIS
Stores all core data elements
65%
Establishes newborn record within 6 weeks of birth
83%
Enable real-time access to and retrieval of immunization information
100%
Receive and process immunization information within 1 month of vaccine 78%
administration
Protect the confidentiality of health care information
100%
Ensure security of health care information
100%
Exchange immunization records using Health Level Seven (HL7) standards
77%
Forecast immunizations needed according to ACIP schedule
96%
Identify individuals due or late to support reminder/recall
98%
Generate coverage reports by providers, age groups, and geographic areas
92%
Produce official immunization records
100%
Promote accuracy and completeness of registry data
98%
immunizations needed, based upon the child’s immunization history in the IIS and the vaccines
needed according to ACIP recommendations. These functionalities are key to supporting clinical
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decision-making for immunization providers. Most IIS (92%) reported the capacity to generate
immunization coverage reports by various criteria, such as county, zip code, age groups, and even
race/ethnicity, a function key to identifying areas or populations with low coverage, thus
supporting the planning of targeted immunization interventions. One such intervention,
reminder/recall notices, could be supported by 98% of IIS. Eighty-three percent of IIS reported
that they could enroll a newborn in their geographic jurisdiction within six weeks of birth, and
78% reported the capacity to receive and incorporate immunizations into a child’s record within
one month of administration. Because a child’s first dose of most vaccines in the childhood
immunization schedule are due at two months of age (“Recommended,” 2015), the availability of
a demographic record in the IIS at the time of that visit is key to supporting immunization
providers in immunization decision-making and documentation for that visit, and for every other
visit thereafter. In addition, because the child’s next immunization visit is at four months of age
(“Recommended,” 2015), it is critical that the immunizations administered at the two-month visit
be included in the child’s IIS record to support clinical decision-making at that next encounter.
Seventy-seven IIS reported the ability to receive and process immunization data transmitted to
their system electronically following Health Level 7 (HL7) standards. Health Level 7 is an
international data exchange standard, and is also standard required by CMS for meeting the
Meaningful Use immunization measure. This capacity, therefore, is essential for EHR-IIS
Interoperability and for receiving updates to child immunization records in the IIS via electronic
transmission. Finally, only approximately two-thirds of IIS reported that they could capture all of
the core data elements for IIS. A complete list of these data elements is provided in Appendix A,
but a list of selected core data elements is listed in Table 2, along with the percentage of IIS
reporting these fields as being populated within their system. As made evident by these data,
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patient race and ethnicity were populated in only approximately one half to two-thirds of
demographic records in IIS for children less than six years of age. Along with vaccine
manufacturer and lot number, which were populated in 66% and 70% of IIS records respectively,
these fields are not only key in the documentation of immuzations, but also in documentation
requirements for the Vaccines for Children program.
Table 2: Percentage of IIS records with select core data elements populated for children <6 years
of age, U.S. National Average, Immunization Information Systems Annual Report, 2013
(Cardemil, 2014).
IIS Core Data Element
Mother’s first name
Mother’s last name
*Patient race
*Patient ethnicity
*Vaccine manufacturer
*Vaccine lot number

% Populated in IIS
77%
67%
65%
54%
66%
70%

*Required by NVICP to be recorded in patient record

2.3

Adoption of EHR in the United States
A supplemental search was conducted to identify what was known in the literature about

the adoption of EHR in the United States, both overall and among the specialties who deliver
immunizations.
In a January 2014 National Center for Health Statistics (NCHS) data brief, Hsiao and Hing
reported results and trends found in the National Ambulatory Medical Care Survey (NAMCS), a
nationally representative annual survey of office-based physicians. The data collected from 2001
through 2013 show that approximately 18% of office-based physicians in 2001 used any type of
either partial or fully electronic medical or health record system. Use increased steadily by 39
percentage points to 57% in 2011, then over two years rose over twenty percentage points to
78.4% in 2013. Adoption of “basic” systems meeting selected criteria rose from 10.5% in 2006 to
21.8% in 2009, when incentive payments for EHR adoption were authorized by the HITECH Act.
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From 2010 to 2013, this adoption rate increased another 26.3 percentage points, reaching 48.1%.
The adoption of EHRs that supported reporting to IIS increased from 26.9% in 2010 to 39.1% in
2013 (Hsiao & Hing, 2014).
When evaluating the adoption of EHR by family physicians, Xierali et al. found that 68%
of practices in this specialty had implemented EHR by 2011, and that this medical specialty is
adopting EHR at a faster rate than other specialties (2013). Although there were variations in the
level of adoption across the country, the rate of adoption doubled from 2005 and was projected to
reach 80% by 2013.
Leu et al. surveyed a sample of members of the American Academy of Pediatrics (AAP)
in 2009, seeking to characterize the adoption of EHR by pediatricians, who deliver the bulk of
childhood immunizations (2012). The authors found that self-reported EHR use was 41%, lower
than the general level of adoption, but only 25% of this group used systems that met the definition
of having “basic” functionality. They also found that an even lower proportion, just 3%, used
systems the authors considered to be “pediatric supportive.” To be termed “pediatric supportive,”
an EHR had to support five fundamental features for pediatric practice, including immunization
tracking. The authors found that barriers to EHR adoption were primarily financial in nature, but
also were related to concerns as to how implementation and use of the software would impact
office productivity, and also how well it would meet their practice’s needs (Leu et al., 2012).
Lehmann, O’Connor, Shorte, and Johnson conducted a similar follow-up survey of AAP
members in 2012. They found that the number of office-based pediatricians using EHR had risen
to almost 80%. In addition, the percent of pediatricians using EHRs increased from 58% in 2009
survey to 79% in 2012. Thirty-one percent of pediatricians used “basic” EHRs, and only 8% used
“pediatric supportive” EHRs. As with the previous survey, the authors found that costs associated
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with implementing EHR remained a concern, as did the potential negative effect on productivity.
The authors also state that while the benefits of EHR use to improve quality of care have been
widely promoted, they believe that EHRs that support pediatric practice may be less than desired,
and point out that pediatricians’ voices must be heard in the development and certification process
for EHR to improve functionality, efficiency, and data exchange capability (Lehmann et al.,
2015).
2.4 EHRs and EHR-IIS Interoperability
A supplemental search was conducted to identify what was known in the literature about
EHR–IIS interfaces and the status of EHR adoption by pediatric providers in the United States.
Bundy et al. (2013) evaluated EHR-derived immunization prompts in a urban hospitalbased pediatric and primary care clinic, meant to call provider’s attention to overdue vaccinations
and reduced missed opportunities for immunization (when a child presents in the office and could
receive a vaccination, but does not). EHR-delivered immunization prompting was found to be
insufficient to improve immunization rates among the study population that already had baseline
coverage (Bundy et al., 2013).
Merrill, Phillips, Keeling, Kaushal and Senathirajah (2013) evaluated the impact that
EHR-based HL7 reporting had on their routine reporting of immunizations to the New York
Citywide Immunization Registry (NYCIR) compared to their legacy reporting format.
Comparing median pre-implementation and post-implementation timeliness and completeness
measures, the authors found that the proportion of new immunizations reported to the NYCIR
rose by 18%, and historical immunizations (those reported more than one year since
administration) rose 98%. They also found that the number of immunizations reported in less
than two days rose by 17% and that the median time from reporting to receipt in the NYCIR
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decreased from 13 days to 10 days. Despite the overall positive impact, the authors did find that
documentation of VFC eligibility decreased by 8%. Upon further investigation, this decrease was
attributed to EHR workflow. They found that the EHR did not have a field to capture Medicaid
ID, which was a means by which the practice determined VFC eligibility. Rather than capture
Medicaid ID, the EHR’s immunization reporting module had more than one field where VFC
eligibility status could be documented, however the data extraction process pulled eligibility
information from only one of these fields. Unless entered in the field included in the download
and batch submission, status was not captured and sent to the NYCIR (Merrill et al., 2013).
Hills, Revere, Altamore, Abernethy and Lober (2012) compared the quality of data
submitted to the Washington State IIS from provider site EHR using HL7 format to a flat file,
non-standard format. They examined several demographic and vaccination data fields, however
none of these data elements were the same as those examined in this study. The authors found
that data received via HL7 were more timely but that flat file data were more complete (Hills et
al., 2012). Schauer, Maerz, Verdon, Hopfensberger and Davis (2014) also compared timeliness
and completeness of data received within a state IIS submitted via HL7 and flat file formats.
They evaluated data from provider site EHR to the Wisconsin Immunization Registry (WIR)
using the HL7 standard format compared to a flat file, non-standard, format. Three of the data
elements they evaluated were vaccine manufacturer, vaccine lot number, and VFC eligibility.
Overall, they found that data submitted via HL7 interfaces were more timely and complete than
via flat file. Specifically, vaccine manufacturer data reporting increased from 42% to 62%, lot
number reporting increased from 26% to 63%, and VFC eligibility reporting increased from 0%
to 95% (Schauer et al., 2014).
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2.5

Summary
Overall, the use of IIS to support Community-Guide recommended interventions to

increase immunization is well-documented, not only within the original scope of the Task Force’s
systematic review, but also for children less than six years old in population-based IIS in the
United States. The literature also documents the capacity of IIS to support a wide array of
evaluation studies, both for immunization coverage and delivery. The use of race/ethnicity and
vaccine manufacturer and lot number fields is documented in multiple studies, illustrating that
these fields are key not only to VFC program accountability, but also to public health research in
immunization. A review of IIS functional status in 2012 indicate that almost all IIS could support
immunization forecasting as well as reminder recall, but also that about two thirds of IIS could
capture all core data elements, and approximately three-quarters of IIS could exchange
immunization records using HL7 standards in 2012.
Findings regarding use of EHR in the United States indicate that providers are responding
to the CMS Meaningful Use incentive program and implementing EHR in their practices, but that
pediatric practices are adopting EHR at a slower rate. Also documented is that many EHR do not
have the functionality to appropriately support pediatric practice, and that only a small percentage
of EHR implemented among pediatric practices can support immunization tracking. Studies
examining the effect of EHR-IIS interoperability on completeness of data in IIS are few, and
those available reported contrasting results regarding the timeliness and completeness when
comparing HL7 versus non-standard data exchange formats. The study that did find HL7 to
provide more complete data also found increased completion in some of the fields of interest in
this study. Both of these studies examined data within only one IIS; this study is the first to
examine data collected at the provider site level across multiple states.
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Chapter III
METHODS AND PROCEDURES
3.1 Data
A cross-sectional design was used to conduct this study. Data used for the study was
provided by fifteen IIS who received both ARRA-HITECH and PPHF 2012 funding for EHR-IIS
interoperability projects. As part of their project requirements, these IIS queried their system data
to produce benchmarking metrics on immunization and demographic data reported to them by
provider sites with which they had implemented HL7 interfaces (ARRA, 2015; DHHS, 2015).
Data were collected prior to HL7 implementation (“pre-enhancement”) and after HL7
implementation (“post-enhancement”). Post-enhancement queries were conducted every 90 days
after implementation until the end of the given project period. Once queries were completed, IIS
recorded the benchmarking metrics for each provider site in a secure website. Benchmarking data
for the ARRA-HITECH projects were collected from September 1, 2010 through November 30,
2012. Benchmarking data for PPHF 2012 projects were collected from September 30, 2012
through November 30, 2014. Provider sites selected for inclusion in the study were those that
collaborated on HL7 interface development with IIS during both the ARRA-HITECH and PPHF
2012 interoperability projects, and for whom benchmarking data was collected and reported. No
individually-identifiable data were collected as a part of this project; only aggregate data were
used. The data were from a non-public CDC data set, and author was given permission to use
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these data by CDC. The benchmarking data set fields selected for analysis captured data related
to up-to-date immunization status for 19 to 35 month-old children, population of selected
demographic data fields, and population of selected vaccine fields. The variables collected by IIS
for provider sites at pre-enhancement and post-enhancement and their use in the study are
identified and listed in Table 3.
Table 3: EHR-IIS Interoperability Benchmarking Dataset Field Codes, Description and Use in
Study Analysis
Dataset Field
Codes

Description of Key Study Variables

Use in
Analysis

series431331Prop

Proportion of children aged 19 to 35 months for 4:3:1:3:3:1,
(4 or more DTaP/DTP/DT, 3 or more Polio, 1 or more MMR,
3 or more Hepatitis B, ≥3 or ≥4 of Hib, and 1 or more
Varicella) at the provider sites as of the benchmarking date

Up-to-Date
Status

iis435

Number of children aged four months to six years at the
provider site as of the benchmarking date

Demographic
Data
Completeness

numNVAC4

Number of children aged 4 months to six years at the provider
site with mother’s first name, mother’s last name, and patient
race and ethnicity populated in their demographic record in
the IIS as of the benchmarking date

Demographic
Data
Completeness

iis435NumVac

Number of vaccinations reported to the IIS by the provider
site for children aged four months to six years at preenhancement as of the benchmarking date

Vaccine Data
Completeness

iis4m6yNumVac

Number of vaccinations reported to the IIS by the provider
site for children aged four months to six years at postenhancement as of the benchmarking date

Vaccine Data
completeness

numNVAC2

Number of vaccinations reported to the IIS by the provider
site for children aged four months to six years with vaccine
manufacturer and lot number populated in the IIS as of the
benchmarking date

Vaccine Data
Completeness
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3.2 Data Analysis Plan and Methods
This study analyzed benchmarking metrics from provider sites participating with these 15
IIS to examine the change in up-to-date immunization status of 19 to 35 month-olds and the
completion of demographic and vaccine fields in IIS from prior to HL7 interface implementation
(pre-enhancement) to after HL7 interface implementation (post-enhancement).
Reported pre-enhancement and post-enhancement data sets for that collaborated on HL7
interface development with IIS during both the ARRA-HITECH and PPHF 2012 interoperability
projects were matched by provider site ID, and analyses were performed on the matched pairs of
metrics reported for each site. Because IIS provided several sets of post-enhancement
measurements at 90-day intervals for each provider site after HL7 implementation, the most
recent post-enhancement measurement at each provider site was selected in order to allow the
greatest possible elapsed time after enhancement, and consequently to allow the greatest possible
time for the intervention’s intended effect.
Because the number of children in the age groups of interest varied widely across the
provider sites included in the analyses, proportions were calculated and compared rather than the
actual number of children up-to-date or demographic or vaccination records. After matching the
pre-enhancement and post-enhancement data sets for each provider site, the proportion of
demographic and vaccine records considered complete at pre-enhancement and at postenhancement were calculated. To be considered complete, the IIS had to have both vaccine data
fields and all four demographic data fields populated in the IIS, for the vaccine data completeness
and demographic data completeness analysis, respectively. Proportions for the analysis were
calculated as follows:

32

Demographic Data Completeness, Pre-enhancement:

iis435
numNVAC4

Demographic Data Completeness, Post-enhancement:

iis435
numNVAC4

Vaccine Data Completeness, Pre-enhancement:

iis435NumVac
numNVAC2

Vaccine Data Completeness, Post-enhancement:

iis4m6yNumVac
numNVAC2

As seen in Table 3, the proportion of children up-to-date for the 4:3:1:3:3:1 vaccination series at
pre- and post-enhancement had already been calculated and no further calculation for this analysis
was needed.
Test statistics were performed on the dependent pairs to determine if the mean difference
in the proportion of children in up-to-date status or the proportion of demographic or vaccine data
fields populated in IIS from pre-enhancement to post-enhancement for these measures was
statistically significant. Because the sample sizes for each analysis were greater than 30, the
Central Limit Theorem applied and the following test statistic was used with an accompanying
hypotheses and decision rule:

Test Statistic:
Null and Alternate Hypotheses:

H0: μd = 0
H1: μd > 0

Decision Rule:

α = 0.05

Reject H0 if Z ≥ 1.96 or if Z ≤ -1.96
Do not reject H0 if -1.96 < Z < 1.96
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Chapter IV
RESULTS
The following section will describe the findings of this evaluation study and address the
following research questions:
1) Does interoperability between EHR and IIS improve immunization outcomes?
2) How can EHR-IIS Interoperability improve the capacity of IIS to support activities
to increase appropriate immunization?
4.1

Results
Sixty-three state- and city-level IIS are currently operating in the U.S. Twenty of these IIS

(31.7%) received ARRA funding to perform EHR-IIS interoperability projects in 2010, and
fifteen of these twenty, roughly a quarter of all operational IIS, were funded a second time in
2012 with ACA-PPHF funds. From these fifteen IIS, provider sites were identified that had been
included in both ARRA and PPHF projects. After data cleaning, of those provider sites, fortyeight were identified for the 4:3:1:3:3:1 up-to-date analysis from six statewide and one citywide
IIS, and 47 provider sites were identified for the demographic and vaccination record
completeness analysis from five statewide and one city-wide IIS. Table 4 lists the number of
provider sites included from each IIS.
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Table 4: Number of Provider Sites Enhanced, ARRA-HITECH and PPHF 2012, and
Number of Provider Sites Included in UTD and Completeness Analyses, by IIS
IIS

Number of
Sites
Enhanced ARRA

A
76
B
237
C
25
D
210
E*
7
F
56
G
90
TOTAL
701
*indicates city-wide IIS

Number of
Sites
Enhanced PPHF

Sites
Included in
UTD
Analysis

Sites
Included in
Completeness
Analyses

60
149
222
200
45
16
268
960

4
26
1
3
5
1
8
48

4
26
1
3
5
0
8
47

For the provider sites included in the 4:3:1:3:3:1 up-to-date analysis, the HL7 interface
had been established an average of 927 days (30.8 months) prior to the most recent postenhancement measurement used, with a range of 270 (9.0 months) days to 1,346 days (44.9
months). For the provider sites included in the demographic and vaccination record completeness
analysis, the HL7 interface had been established an average of 919 days (30.6 months) prior, with
a range of 181 days (6.0 months) to 1,346 days (44.9 months).
Results of the statistical analysis are displayed in Table 5.
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Table 5: Comparison of Mean Differences in Proportion of Children UTD and Field
Completeness for Selected EHR-IIS Interoperability Measures
Interoperability
Benchmarking
Measure
Up-to-Date Status
UTD for 4:3:1:3:3:1
19-35 month-olds

Sample
Mean Xd
3.61

Std Dev
Difference sd
18.64

Z-statistic

C.I.

1.34

3.61 + 5.29
(-1.72,8.94)

Completeness
Mother’s First Name
& Last Name,
Child’s Race & Ethnicity
4 month to 6 year olds

16.09

25.31

4.36

16.09 + 7.2
(8.86,23.33)

Vaccine Manufacturer
& Lot Number
4 month to 6 year olds

17.33

32.17

3.69

17.33 + 9.2
(8.13,26.73)

4.2

UTD Status for 19-35 month olds
The analysis of benchmarking data for the up-to-date status for 19 to 35 month olds

confirmed the null hypothesis. The Z-statistic of 1.34 failed to demonstrate sufficient evidence at
.05 alpha to show that the mean difference in the proportion of children UTD for the 4:3:1:3:3:1
series in this age group at enhanced provider sites after EHR-IIS enhancement was greater than
zero. The confidence interval for this statistic showed 95% confidence that the a mean change in
up-to-date status for 19 to 35 month-olds at enhanced provider sites was between -1.73% and
8.61%.
4.3

Completeness of Demographic Data
The results of the analysis for the completion of the four selected demographic data

elements (Mother’s First Name, Mother’s Last Name, Child Race and Child Ethnicity) in IIS for
children aged four months to six years supported the study’s hypothesis. The Z-statistic of 4.36
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demonstrated sufficient evidence at .05 alpha to show that the mean difference in the proportion
of children in this age group at provider sites with completed demographic data in the IIS after
enhancement was greater than zero. The confidence interval for this statistic showed 95%
confidence that the mean change in completeness for the selected demographic data elements for
children aged four months to six years at enhanced provider sites was between 8.86% and
23.33%.
4.4 Completeness of Vaccine Data
The results of the data analysis for the completion of the two selected vaccine data
elements (Vaccine Manufacturer and Vaccine Lot Number) in IIS for children aged four months
to six years supported the study hypothesis. The Z-statistic of 3.69 demonstrated sufficient
evidence at .05 alpha to show that the mean difference in the proportion of children in this age
group at provider sites with completed vaccination data in the IIS after enhancement was greater
than zero. The confidence interval for this statistic showed 95% confidence that the mean change
in completeness for the selected vaccine data elements for children aged four months to six years
at enhanced provider sites was between 8.13% and 26.73%.
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Chapter V
DISCUSSION AND CONCLUSION

5.1 Discussion of Research Questions
The purpose of this research study was to answer the question of whether interoperability
between EHR and IIS improve immunization outcomes.
The first immunization outcome of interest in this study is the up-to-date status for 19 to 35
month old children. Findings indicated that, at the provider sites included in this study, this
outcome did not improve. The EHR-IIS interfaces may have contributed to some initial increase
in up-to-date status simply by consolidating immunization records, as was found in Stille et al.’s
2000 study, however any change in the mean difference in the proportion of 19 to 35 month-old
up-to-date children was not statistically significant. There are several factors that could explain
this outcome, such as the nature of the metric used for evaluation. During the course of each
provider site’s involvement in the EHR-IIS interoperability project with the IIS, the up-to-date
status for children aged 19 to 35 months was being evaluated every 90 days. Because the children
selected for inclusion in the age group being evaluated for up-to-date status were identified by
date of birth relative to the date of evaluation, children would age in and out of the group over
time, and so the same group of children was more than likely never assessed more than once.
New patients who were behind on immunizations could have also joined the practice during the
project period and included in any given up-to-date evaluation, thereby lowering the coverage rate
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for the practice. In addition, if any new patient’s previous immunizations were either not reported
to the IIS by their previous provider, or if records of prior immunization were not provided by the
parent, then the child could truly be up-to-date yet lack the documentation to prove it.
Other factors related to human behavior or to the interface itself may also have been at play. It
is possible that immunizations administered at the provider practice were not being consistently
entered into the EHR for reporting to the IIS, or also that immunizations in the EHR were not
being consistently captured during data extraction for transmission to the IIS. In addition,
providers may not be either consulting the IIS for recommended immunizations during each
patient visit, thereby missing opportunities to catch the child up to schedule. Also, the interface
between the EHR and IIS may not have been bi-directional, which could have harmonized the
data in the EHR and IIS and also delivered immunization recommendations to be displayed in the
provider’s EHR. Providers could also have been following parental desires to follow alternative
immunization schedules and intentionally delay immunizations; children of these parents would
therefore appear to be behind on immunizations according to the ACIP recommended schedule.
This study yielded more favorable findings regarding the outcomes of interest related to IIS
data completeness. The results for both vaccine data and demographic data completeness
demonstrated that EHR-IIS interoperability favorably impacted these measures, similar to the
findings of Shauer et al. (2014).
The mean difference in vaccination records with both vaccine manufacturer and lot
number and demographic records with mother’s first name, last name, and child’s race and
ethnicity populated in the IIS was shown to have a statistically significant increase. An important
consideration in the completion of vaccine manufacturer and lot number completeness outcome is
that these data are key to vaccine ordering and inventory management, and in the case of
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providers participating in the VFC program, they are required and therefore crucial to provider
business. Vaccine manufacturer and lot number, along with child race and ethnicity, are also
required by the VFC program for eligibility tracking purposes. IIS can support documentation of
vaccine manufacturer and lot number by pre-populating these fields with known inventory on
hand, avert documentation errors by employing edit checks, thereby simplifying vaccine
documentation and improving accuracy. Also at play is that immunization programs are
increasingly requiring IIS reporting as a part of VFC program participation and relying on their
IIS to support VFC accountability activities (Use of IIS as a VFC Requirement, 2015).
As seen in the calendar year 2013 IISAR data, data completeness for individual fields is
variable. To be included in the count of records considered “complete” for this study, data needed
to be in both or all four of the vaccination or demographic fields, respectively. If completeness of
each field were queried individually, completion rates might have varied and potentially revealed
a greater increase in completeness than was yielded in this study. Another important
consideration is that although this study yielded positive findings with regard to data element
completeness, the quality of those data was not evaluated. Though it was found that data fields
were more complete, it is unknown if the data contained in these fields were valid. Data
completeness could also be affected by the capacity of EHR to capture these data elements; there
are thousands of EHR products in the marketplace, (Office of the National Coordinator for Health
Information Technology, 2015), the capacity of each one of these products is challenging to
catalogue and the criteria by which these products are certified may not be fully in alignment with
pediatric needs (Spooner, 2012). In addition, it is unknown to what extent EHR users at provider
sites have been trained to enter these data, or even if entering data in these fields is required. Both
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user training and data entry requirements could therefore play a role in completion of
demographic and vaccination records.
Also under consideration as a part of this study is the broader question of how EHR-IIS
interoperability can support activities to increase appropriate immunization. IIS capacity to
perform coverage analysis as well as completion of the data elements of interest in this study are
central to answering this question.
Although in this study EHR-IIS interoperability was not shown to increase up-to-date status
for 19 to 35 month old children, other studies have shown IIS to be useful in conducting coverage
analysis for this as well as any number of other age groups. By supporting the consolidation and
availability of immunization status for children within the jurisdiction of an immunization
program, IIS are a powerful tool for identifying factors contributing to suboptimal coverage
among specific subgroups. Because IIS can also support coverage analysis at the provider level,
they support evaluation of immunization provider performance and adherence to the ACIP
recommended vaccination schedule. Providers who are not following recommended
immunization guidelines or taking every opportunity to assess immunization status can then be
contacted by the program for education. By evaluating coverage at numerous levels, IIS can
provide valuable information to programs to support addressing barriers to appropriate
immunization among all components of the immunization delivery system. Using that
information, programs can then develop new approaches to reach underimmunized groups and
ensure that levels of protection against VPDs are consistent throughout the population.
The specific demographic and vaccine data of interest in this study and their inclusion in IIS
are key to supporting initiatives to increase appropriate immunization. Although most IIS can
capture child race, child ethnicity, vaccine manufacturer, and vaccine lot number, according to
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2013 IISAR data, IIS have room to improve in the completeness of these fields. These fields are
key to VFC program administration, and because EHR-IIS interfaces can automate the
documentation and reporting process for VFC providers, EHR-IIS interoperability can yield
improved field completion rates, eligibility documentation and vaccine management in IIS and for
immunization programs. When documentation and accountability improve, the program’s
capacity to efficiently manage its publicly-purchased vaccine stock improves as well.
Additionally, with more complete data and immunization decision support, extraimmunization
can be reduced. When considered in the context of averted extra doses for VFC-eligible children,
these efficiencies can translate into dollars saved for the VFC program, which over time could
become substantial.
Increased completion of these key data elements also translates to increased capacity of IIS to
evaluate immunization delivery and develop more effective promotion strategies to reach
underimmunized children. As described above, improved ability to evaluate coverage can
support program efforts to target interventions to those understood to be chronically at risk for
delayed immunization or underimmunization. The improved completion of race and ethnicity
only increases IIS capacity even more to support Community Guide recommended strategies such
as reminder-recall, home visits, and coordination of outreach with other health programs and
physician specialties through consolidation of records, surveillance, and sharing of immunization
information can strengthen the public health safety net and close gaps in coverage.
5.2 Study Strengths and Limitations
This study had key strengths and several limitations. One substantial strength of this study
is that it used provider site-specific data. Because these data were queried and calculated by
provider site, they allow more precise identification of the practice-level factors influencing data
the completeness of data received in IIS via interoperable interfaces at the clinic level. With
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further analysis, these data will continue to support the evaluation of the effects of EHR-IIS
interoperability on immunization outcomes.
There are several limitations in this study. This study had a very small and non-random
sample. The IIS selected, although not identified here, are ones that have high rates of child and
provider participation compared to most IIS in the U.S. These results therefore are not
generalizable, having been produced using data from IIS and provider sites that are more likely to
experience positive change. Another limitation is that the quality of the data in the fields
measured in this study was not assessed, only the completion of the fields. It is unknown whether
or not the data in these fields was valid or not. This study is also limited by the extent to which
the IIS followed the benchmarking logic guidance provided to them. The accuracy of the
benchmarking data is dependent on IIS following the guidance correctly. And finally, these data
were queried and reported by IIS, and as such were self-reported.
5.3 Implications of Findings
Data exchange between EHR and IIS, because of its potential to impact immunization
decision-making for individuals and interventions for populations, has business and clinical
implications for both providers and public health. This study, along with Schauer et al (2014),
shows that EHR-IIS data exchange can yield an increase in IIS data critical for VFC program
management and accountability and immunization program coverage analysis and evaluation.
Provider office staff and EHR vendors play a key role in the success of EHR-IIS interfaces;
providers are responding to the Meaningful Use incentive program, yet evidence suggests that
simply implementing EHR is not enough to yield the intended benefits. Appropriate and accurate
capture of demographic data to support outreach, reminder recall, and other analysis to help target
immunization interventions to under-immunized populations is critical to closing gaps in
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coverage and increasing overall population protection against vaccine-preventable disease. Lack
of accurate address or other contact information was documented in the literature to be a barrier to
receipt of reminder recall notices; although this study examined only four demographic data
elements, other demographic data, such as address and phone number, may be positively
impacted as well.
5.4 Recommendations for Future Research
EHR-IIS interfaces must be carefully tested to assure accurate immunization, demographic,
and VFC-related data are captured in EHR and extracted appropriately for upload into IIS.
Providers should be educated about the functionality of EHR and their capacity to support all
aspects of their clinical practice, including immunization. IIS and immunization programs must
communicate with provider office staff to assure key data are captured in EHR for transmission to
IIS. Because little is known about provider attitudes concerning IIS, their confidence in IIS data
and their immunization recommendations, research on provider opinions is critically needed. The
capacity of EHR to support immunization data capture, as well as bi-directional capability and
receipt and display of IIS-generated immunization recommendations should be examined. Other
methods for examining the impact of EHR-IIS Interoperability on up-to-date status, such as
evaluation of a static group of children, should be explored. Due to the value and importance of
the VFC program, research must be conducted to determine the impact of IIS-based VFC
eligibility and inventory tracking on the VFC program, and the additional impact of EHR-IIS
interoperability on these crucial activities.
Additional analysis of EHR-IIS interoperability benchmarking data should be conducted.
Potential analyses of these data include looking at outcomes by enhancement type, by IIS, by
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EHR vendor, by HL7 version, by length of time since the implementation of an HL7 interface,
and by prior IIS reporting method.
5.5 Conclusion
Immunization is an intervention proven to reduce illness save lives, yet challenges to
achieving and sustaining adequate coverage remain. Lack of access, scattered documentation of
immunization and constantly evolving vaccines and associated recommendations contribute
substantially to suboptimal coverage. The VFC program, by eliminating financial barriers to
immunization, seeks to improve protection in minority and poorer populations, yet participation
entails many administrative tasks. As documented in the literature, immunization information
systems can lower these barriers by supporting documentation, coverage analysis, and proven
interventions to increase coverage. National health information technology policy is
simultaneously driving the adoption of EHR by health care providers and supporting the exchange
of immunization data between EHR and IIS, but the literature shows that simply implementing an
EHR is insufficient to yield the desired benefits. These systems must be selected with careful
thought to practice needs and implemented to ensure appropriate data capture both on the provider
site and during extraction for transmission through an electronic interface. Little is documented
about the effects of EHR-IIS interoperability on the data in IIS, but this study produced results
that are consistent with published findings, specifically the increase in the completion of data
fields key to VFC program management and coverage analysis for vulnerable populations.
Additional research should be conducted to identify the factors contributing to successful EHRIIS interfaces. IIS have the capacity to coordinate and harmonize the multiple components of
immunization delivery in the United States, and by streamlining reporting to IIS, EHR-IIS
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interoperability can accelerate the growth of IIS and, in turn, empower public health to assure
equal protection against disease and disability associated with vaccine preventable disease.
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Appendix A
Table 6: IIS Core Data Elements (CDC, “IIS – Functional Standards - Vaccines,” 2012).
Patient ID (previously listed as “Medicaid
Patient Telephone Number Type (e.g., home,
Number”)
cell)
Patient ID: Assigning Authority ID (i.e.,
Patient E-mail Address
owning source)
Patient ID: Type (e.g., medical record
Patient status indicator—Provider facility level
number, IIS ID)
Patient Name: First
Patient status indicator—IIS level
Patient Name: Middle
Vaccine Product Type Administered
Patient Name: Last
Vaccination Administration Date
Patient Alias Name: First
Vaccine Manufacturer Name
Patient Alias Name: Middle
Vaccine Lot Number
Patient Alias Name: Last
Vaccine Expiration Date
Patient Date of Birth
Vaccine dose volume and unit
Patient Gender
Vaccine Site of Administration
Patient Multiple Birth Indicator
Vaccine Route of Administration
Patient Birth Order
Vaccine Ordering Provider Name
Responsible Person Name: First
Vaccine Administering Provider Name
Responsible Person Name: Middle
Vaccine Administering Provider Suffix (e.g.,
MD, RN, LPN)
Responsible Person Name: Last
Vaccination Event Information Source (i.e.,
administered or historical)
Responsible Person Name: Relationship to
VFC/grantee program vaccine eligibility at dose
Patient
level
Mother’s Name: First
VIS Type & Publication Date
Mother’s Name: Middle
VIS Date given to patient
Mother’s Name: Last
Contraindication/Precaution(s)
Mother’s Name: Maiden Last
Contraindication/Precaution(s)Observation Date
Patient Address: Street
Exemption(s)/Parent Refusal(s) of Vaccine
Patient Address: City
Date of Exemption(s)/Parent Refusal(s) of
Vaccine
Patient Address: State
Vaccine Reaction(s)
Patient Address: Country
History of vaccine preventable disease (e.g.,
varicella)
Patient Address: Zipcode
Date of History of Vaccine Preventable Disease
Patient Address: County of Residence
Race
Ethnicity
Birthing Facility Name
Patient Birth State
Patient Primary Language
Patient Telephone Number

